Normal view MARC view ISBD view

Combining immunotherapy and epidermal growth factor receptor kinase inhibitors: worth the risk?.

Combining immunotherapy and epidermal growth factor receptor kinase inhibitors: worth the risk?. - 2019

English

ISSN: 2305-5839

Standard No.: 10.21037/atm.2019.03.6 [doi] atm-07-S3-S76 [pii] PMC6685870 [pmc]

Subjects--Topical Terms:
IN PROCESS -- NOT YET INDEXED

Subjects--Geographic Terms:
Washington Cancer Institute

Index Terms--Function:
Comment
Editorial

Print
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)